UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000030979
Receipt No. R000035374
Official scientific title of the study Study on an effect of continuous intake of a test food product on relieving a feeling of fatigue
Date of disclosure of the study information 2018/01/29
Last modified on 2018/07/11 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Study on an effect of continuous intake of a test food product on relieving a feeling of fatigue
Title of the study (Brief title) Study on an effect of continuous intake of a test food product on relieving a feeling of fatigue
Region
Japan

Condition
Condition Healthy subjects
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To examine an effect of a test food product on reliving a feeling of fatigue after an exercise stress test by selecting those who are aged 30 and over, below 45 and have no exercise habit and assigning them to take the test food product for 1 week on a continuous basis.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes VAS, Creatine kinase, Lactic acid
Key secondary outcomes Hematologic test, blood biochemical test, vital signs

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Food
Interventions/Control_1 1-week intake of the test food
Wash out
1-week intake of the placebo
Interventions/Control_2 1-week intake of the placebo
Wash out
1-week intake of the test food
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
30 years-old <=
Age-upper limit
45 years-old >
Gender Male and Female
Key inclusion criteria 1)Age: 30 and over, below 45
2)Sex: Males and females with Japanese nationality
3)No exercise habit in the last 12 months
*Those who exercise once a week or less, or 2 to 3 times a month will be accepted.
Key exclusion criteria 1)Currently in treatment with medication or seeing a doctor for treatment
2)Previous history of hepatic disorder or severe disorder related to kidney, endocrine, cardiovascular system, gastro-intestine, lung, blood, or metabolism, or currently presence of complications
3)Previous history of drug allergy or food allergy
4)Regular intake of a food product or a supplement with a possible effect on relieving fatigue
5)Regular intake of medication with a possible effect on relieving fatigue
6)Extreme faddiness
7)Extremely irregular lifestyle such as a dietary pattern and a sleeping pattern
8)Sleep disorder(insomnia, sleep apnea syndrome; SAS, etc.)
9)Presence or previous history of mental disorder (depression, etc.)
10)Presence or previous history of alcoholism
11)Current participation in another clinical trial or participation in another clinical trial within the last three months
12)Irregular work hours such as working on night shift
13)Exercise habit (twice a week or more)
14)Determined by the investigator to be unsuitable for enrollment in this study
Target sample size 26

Research contact person
Name of lead principal investigator Takihara Takanobu
Organization ITO EN, Ltd.
Division name Central Research Institute
Address 21 Mekami, Makinohara-shi, Shizuoka 421-0516, Japan
TEL 0548-54-1247
Email t-takihara@itoen.co.jp

Public contact
Name of contact person Ochitani Daisuke
Organization HUMA R&D CORP
Division name Clinical Development Division
Address Oekkusu Bldg10F 5-31-19 Shiba Minato-ku Tokyo 108-0014 Japan
TEL 81-3-3431-1260
Homepage URL
Email ochitani@huma-c.co.jp

Sponsor
Institute HUMA R&D CORP
Institute
Department

Funding Source
Organization ITO EN, LTD.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 01 Month 29 Day

Progress
Recruitment status Completed
Date of protocol fixation
2018 Year 01 Month 12 Day
Anticipated trial start date
2018 Year 02 Month 02 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 01 Month 24 Day
Last modified on
2018 Year 07 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035374